Keefe Bruyette raises Allstate stock price target on faster growth
Keefe Bruyette & Woods raised Allstate's (NYSE:ALL) price target to $241 from $232, citing faster growth expectations. They increased 2026-2028 EPS estimates but maintained an Underperform rating. Allstate's Q3 2026 earnings beat expectations, reporting $9.76 EPS and $17.3B revenue. Piper Sandler adjusted its target to $294 from $300, keeping an Overweight rating.
How this was made
The 30-second read
Why it matters
The analyst upgrade signals a positive earnings outlook but the Underperform rating suggests caution.
Market read
Analyst target revision provides fresh guidance for traders, potentially influencing Allstate's short‑term price action.
What to watch
Potential pressure from personal‑lines price competition and higher core loss ratios may offset earnings upside.
Background
Allstate reported Q3 2026 earnings that beat expectations, prompting analysts to revise forecasts and price targets.
Ticker impact
Keefe, Bruyette & Woods raised its price target on Allstate to $241 and lifted 2026‑2028 EPS estimates after the company posted strong Q3 2026 results.
likely modest upside as the market prices in the higher target despite an Underperform rating
The new target reflects faster earnings growth and higher investment income, which could attract buyers, but the Underperform stance tempers enthusiasm.
Market effects
Higher target may lift sentiment in the property‑casualty insurance sector.
U.S. insurers could see slight price support.
Limited to U.S. equity markets.
Counterpoint
The Underperform rating and higher loss ratios could keep the stock muted despite the target raise.
Key entities
- companyAllstate Corp.
U.S. property‑casualty insurer (ticker ALL).
- analyst_firmKeefe, Bruyette & Woods
Equity research firm that raised the price target.
